Gram-negative Bacterial Infection
📧 Sign up to get email alerts when something new happens for Gram-negative Bacterial Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. [Phase 2]
Phase 2 trial update evaluating pharmacokinetics, safety, and tolerability of ceftazidime-avibactam in neonates and infants; study terminate…
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) [Phase 1]
A Phase 1 pharmacokinetics study of MK-7655A in pediatric participants with suspected or documented Gram-negative bacterial infections has c…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria [Phase 1]
This Phase 1 population pharmacokinetic study evaluates Colistin in patients infected with multidrug-resistant Gram-negative bacteria.
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial [Phase 3]
A Phase 3 randomized trial evaluated whether Polymyxin B protects against sepsis-induced kidney dysfunction; results were posted in 2010.